<DOC>
	<DOCNO>NCT00224419</DOCNO>
	<brief_summary>Nicotine dependence sufficiently address current state-of-the-science cessation intervention pregnant smoker . The weight evidence general population smoker suggest nicotine replacement therapy may beneficial cessation aid pregnant smoker unable stop smoking . The tremendous potential therapy promote smoke cessation among pregnant woman create press need decision tool protocols encourage treatment adherence essential rigorous evaluation effectiveness OTC NRT provide part prenatal care . The result research could directly translate improvement obstetrical care provider ' clinical practice . Medically supervise use OTC NRT pregnant smoker alternative continued smoke potential substantially increase rate smoke cessation pregnancy .</brief_summary>
	<brief_title>Testing Pharmacological Therapies Pregnant Smokers</brief_title>
	<detailed_description>The propose five-year study design evaluate effectiveness provide over-the-counter ( OTC ) nicotine replacement therapy , choice gum , lozenge patch , ( NRT ) promote prepartum smoking cessation . Proposed two-arm design . Eligible pregnant woman ( N=300 ) randomize either : Arm 1 , Tailored Cognitive Behavioral Treatment ( TCBT , n=100 ) provide woman customize risk information smoking nicotine , potential harm fetus encouragement appropriate behavioral skill building ; Arm 2 , TCBT + NRT - tailor intervention incorporate NRT information plus choice patch gum ( n=200 ) . The intervention include 5 face-to-face contact part prenatal visit 1 telephone counseling session . Primary outcome measure biochemically validate 7-day prevalent abstinence rate 19-27th 29-37th week pregnancy . Secondary outcome include 7-day prevalent abstinence rate 12 week postpartum , serious quit attempt , compliance NRT , use material . Saliva cotinine measure among woman baseline , 27-35th week pregnancy , 12 week postpartum . The significance project rely transdisciplinary collaboration extend science nicotine replacement therapy population could derive substantial health benefit . Moreover , study result immediate potential inform clinical recommendation integrate nicotine replacement prenatal care .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Be least 18 year age Be 13 25 week pregnancy Be receive prenatal care one participate clinic Have smoke least 100 cigarette lifetime Be currently smoke smoke least 5 cigarette per day past 7 day Speak write English Evidence cognitive mental health problem Evidence possible drug alcohol addiction Documented history medical chart mental retardation , significant chronic recurrent psychiatric disorder schizophrenia severe depression , history cardiac arrhythmia , history myocardial infarction within past 6 month , history previous pregnancy congenital anomaly , family history congenital anomaly Complications pregnancy current pregnancy , include : threatened miscarriage , congenital anomaly , unexplained vaginal bleeding , pelvic abdominal surgical procedure , deep venous thrombosis , malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Nicotine replacement therapy</keyword>
	<keyword>Motivational interviewing</keyword>
</DOC>